The U.S. and Canadian dollars are always competing in the global exchange market. Similarly, there seems to be a competition in the magic mushroom sector. The number of online mushroom dispensaries in Vancouver and other cities is rapidly increasing. However, the question remains if they can keep up with the fast-paced psychedelic progression in America. Let’s delve deeper.
[toc]
Main Highlights:
- Oregon was the first state to legalize the therapeutic use of magic mushrooms, which are administered by licensed practitioners.
- In 2020, Canada’s Health Minister gave four terminally ill cancer patients the green light to use magic mushrooms for palliative care.
- Clairvoyant is a 24-week Phase 2 trial at the University of British Columbia that is exploring psilocybin-assisted therapy for adults diagnosed with alcohol abuse disorder.
The Rapid Growth of the Magic Mushroom Industry in the United States.
The magic mushroom industry in the U.S. has grown rapidly, becoming the only drug that can compete with cannabis. This quick growth indicates an increasing societal recognition of the substance’s potential for therapeutic use.
Prioritizing Mental Health
Medical professionals are fascinated by its potential to relieve symptoms of mental health conditions, including depression, anxiety, and PTSD. Studies have shown promising results, leading private pharmaceutical companies to explore its medicinal uses.
This trend has not only sparked interest in health care applications but has also significantly boosted the economy. Startups and research projects are focusing on the development of psilocybin.
The amount of clinical evidence supporting the use of magic mushrooms in treating specific diseases is growing. NIDA Director Nora Volkow emphasized the mounting evidence that psychedelics have “significant potential” for medical treatments.
Legal Milestones
- Oregon Measure 109: In 2020, Oregon set a precedent by being the first state to legalize psilocybin for therapeutic use, permitting licensed professionals to administer controlled doses. This significant decision established a model for other states to emulate.
